Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
10.4M
-
Number of holders
-
42
-
Total 13F shares, excl. options
-
1.49M
-
Shares change
-
-2.03M
-
Total reported value, excl. options
-
$3.46M
-
Value change
-
-$33.8M
-
Number of buys
-
23
-
Number of sells
-
-26
-
Price
-
$2.34
Significant Holders of CervoMed Inc. - Common Stock, $0.001 par value (CRVO) as of Q4 2024
60 filings reported holding CRVO - CervoMed Inc. - Common Stock, $0.001 par value as of Q4 2024.
CervoMed Inc. - Common Stock, $0.001 par value (CRVO) has 42 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.49M shares
of 10.4M outstanding shares and own 14.32% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (383K shares), BlackRock, Inc. (324K shares), STATE STREET CORP (116K shares), GEODE CAPITAL MANAGEMENT, LLC (115K shares), Woodline Partners LP (74.9K shares), Perigon Wealth Management, LLC (62.7K shares), NORTHERN TRUST CORP (50.9K shares), MORGAN STANLEY (50.6K shares), UBS Group AG (43.4K shares), and Nuveen Asset Management, LLC (41.6K shares).
This table shows the top 42 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.